Загрузка...
Mutations in specific codons of the KRAS oncogene are associated with variable resistance to neoadjuvant chemoradiation therapy in patients with rectal adenocarcinoma
BACKGROUND: Mutations in KRAS and TP53 are common in colorectal carcinogenesis and are associated with resistance to therapy. Rectal cancers carrying both mutations are less likely to respond to neoadjuvant chemoradiation therapy (CRT) compared to wildtype tumors. Codon-specific KRAS mutations are a...
Сохранить в:
| Опубликовано в: : | Ann Surg Oncol |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5584556/ https://ncbi.nlm.nih.gov/pubmed/23456389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-013-2910-0 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|